Table 4.
Author
Reference |
Country | Study Design | Participants | Changes in the Composition of Gut Microbiota in AIH | Key Findings |
[107] | China | Case-control | 24 AIH 8 healthy controls |
↓ Bifidobacterium
↓ Lactobacillus Escherichia coli and Enterococcus were unchanged |
↑ Intestinal permeability and gut dysbiosis ↑ Bacterial translocation, indicated by increased LPS, was correlated with AIH disease severity |
[104] | Egypt | Case-control | 5 AIH 10 healthy controls |
↑ Faecalibacterium
↑ Blautia ↑ Streptococcus ↑ Veillonella ↑ Eubacterium ↑ Lachnospiraceae ↑ Butyricicoccus ↑ Haemophilus ↑ Bacteroides ↑ Clostridium ↑ Ruminococcaceae ↓ Prevotella ↓ Parabacteroides ↓ Dilaster |
↓ Bacterial diversity in AIH ↑ Butyrate forming bacteria (e.g., Butyricicoccus and Ruminococcaceae) |
[106] | Germany | Case-control | 72 AIH 95 healthy controls 99 primary biliary cholangitis 81 ulcerative colitis |
↑ Proteobacteria
↑ Veillonella ↑ Streptococcus ↑ Lactobacillus ↓ Firmicutes in all groups ↓ Faecalibacterium ↓ Bifidobacterium |
↓ Bifidobacterium in AIH was associated with increased disease activity and failure to achieve remission ↓ α-diversity in AIH patients vs. healthy controls |
[105] | China | Cross-sectional | 119 steroid-naïve AIH 132 healthy controls |
↑ Veillonella
↑ Streptococcus ↑ Klebsiella ↑ Lactobacillus ↓ Clostridiales ↓ Ruminococcaceae ↓ Rikenellaceae ↓ Oscillospira ↓ Parabacteroides ↓ Coprococcus |
↑ LPS biosynthesis ↓ α-diversity Veillonella showed a strong association with AIH and was link with ↑ AST and progression of liver inflammation Veillonella, Lactobacillus, Oscillospira, and Clostridiales have high diagnostic value in AIH |
[111] | China | Case-control | 37 AIH 78 healthy controls |
↑ Veillonella
↑ Faecalibacterium ↑ Akkermansia ↑ Klebsiella ↑ Enterobacteriaceae_unclassified ↑ Megasphaera ↓ Pseudobutyrivibrio ↓ Lachnospira ↓ Ruminococcaceae ↓ Blautia ↓ Erysipelotrichaceae_incertae_sedis ↓ Phascolarctobacterium |
A combination of Bacteroides, Ruminococcaceae, Lachnospiraceae, Veillonella, Roseburia, and Ruminococcaceae could distinguish AIH patients from healthy controls |
[108] | China | Case-control | 32 AIH 20 NAFLD 20 healthy controls |
↑ Escherichia coli
↓ Bifidobacterium ↓ Lactobacillus ↓ Bacteroides ↓ C. leptum |
↑ Serum LPS in comparison to NAFLD and healthy controls |
AIH, autoimmune hepatitis; LPS, lipopolysaccharide; NAFLD, nonalcoholic fatty liver disease; SCFAs, short-chain fatty acids; ↑, increase; and ↓, decrease.